IGF2BP1 and ovarian cancer: The abnormal expression of m6A-related regulatory enzymes including METTL3, FTO, ALKBH5, IGF2BP1, YTHDF1, and YTHDF2 is closely linked with the growth, metastasis, invasion, and chemotherapy resistance in ovarian cancer 50.